CN Patent

CN104271602B — 双特异性抗体

Assigned to Wuhan Youzhiyou Biopharmaceutical Co ltd · Expires 2020-08-21 · 6y expired

What this patent protects

本申请提供双特异性抗体，其由单链单元和单价单元组成，其中该单链单元针对免疫细胞具有特异性，该单价单元针对肿瘤细胞或微生物具有特异性。该单链单元包含与Fc片段融合的单链可变片段(scFv)且该单价单元包含轻链和重链对。本申请还提供双特异性抗体的制备方法，这些抗体的药学用途和诊断用途。

USPTO Abstract

本申请提供双特异性抗体，其由单链单元和单价单元组成，其中该单链单元针对免疫细胞具有特异性，该单价单元针对肿瘤细胞或微生物具有特异性。该单链单元包含与Fc片段融合的单链可变片段(scFv)且该单价单元包含轻链和重链对。本申请还提供双特异性抗体的制备方法，这些抗体的药学用途和诊断用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN104271602B
Jurisdiction
CN
Classification
—
Expires
2020-08-21
Drug substance claim
No
Drug product claim
No
Assignee
Wuhan Youzhiyou Biopharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.